TMO — Thermo Fisher Scientific Inc

Ownership history in Lipe & Dalton  ·  2 quarters on record

This page tracks every 13F SEC filing in which Lipe & Dalton reported a position in Thermo Fisher Scientific Inc (TMO). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
2.6% (2025 Q4)
Avg. % of fund
2.33%
First filed
2025 Q2
Last filed
2025 Q4
Quarters held
2
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 REDUCED 9,100 -304 -3.2% 2.60% $5.3M $578.88
2025 Q2 INITIATED 9,404 — — 2.06% $3.8M $404.39
% of Fund (quarterly)    TMO price (monthly, adj. close)

Other funds also holding TMO

As of 2025 Q4 — sorted by position size

Spinecap SAS 15.68% Cryder Capital Partners LLP 3Y 7Y 12.9% Lindsell Train Ltd 3Y 7Y 10.13% Unisphere Establishment 8.49% C Partners Holding GmbH 3Y 7Y 8.48% R.H. Dinel Investment Counsel, Inc. 3Y 7Y 7.61% Arvin Capital Management LP 7.4% CALEDONIA INVESTMENTS PLC 3Y 7Y 7.18% Veritas Asset Management LLP 3Y 7Y 6.72% EdgePoint Investment Group Inc. 3Y 7Y 6.59%
← Back to Lipe & Dalton Holdings